Modifications of DNA by platinum complexes. Relation to resistance of tumors to platinum antitumor drugs.
about
Effect of a monofunctional phenanthriplatin-DNA adduct on RNA polymerase II transcriptional fidelity and translesion synthesisC-Jun N-terminal kinase signalling pathway in response to cisplatinStructural and mechanistic studies of polymerase bypass of phenanthriplatin DNA damageDifferential cytotoxic activity of a novel palladium-based compound on prostate cell lines, primary prostate epithelial cells and prostate stem cellsHeteroleptic mononuclear compounds of ruthenium(ii): synthesis, structural analyses, in vitro antitumor activity and in vivo toxicity on zebrafish embryos.Cytotoxic efficacy of a novel dinuclear platinum(II) complex used with anti-MUC1 in human breast cancer cells.A dual-targeting, p53-independent, apoptosis-inducing platinum(II) anticancer complex, [Pt(BDI(QQ))]Cl.Platinum nanoparticles induce damage to DNA and inhibit DNA replicationRuthenium-based chemotherapeutics: are they ready for prime time?Effects of monofunctional platinum agents on bacterial growth: a retrospective study.Understanding and improving platinum anticancer drugs--phenanthriplatinAnti-cancer effects of newly developed chemotherapeutic agent, glycoconjugated palladium (II) complex, against cisplatin-resistant gastric cancer cells.Conformation and recognition of DNA modified by a new antitumor dinuclear PtII complex resistant to decomposition by sulfur nucleophiles.Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells.Gold-containing indoles as anticancer agents that potentiate the cytotoxic effects of ionizing radiation.Bis-picolinamide Ruthenium(III) Dihalide Complexes: Dichloride-to-Diiodide Exchange Generates Single trans Isomers with High Potency and Cancer Cell Selectivity.DNA-Binding and Topoisomerase-I-Suppressing Activities of Novel Vanadium Compound Van-7Synthesis, Structural Characterization, and Cytotoxic Activity of Novel Paramagnetic Platinum Hematoporphyrin IX Complexes: Potent Antitumor AgentsNovel Anticancer Platinum(IV) Complexes with Adamantylamine: Their Efficiency and Innovative Chemotherapy Strategies Modifying Lipid Metabolism.Triptolide avoids cisplatin resistance and induces apoptosis via the reactive oxygen species/nuclear factor-κB pathway in SKOV3(PT) platinum-resistant human ovarian cancer cells.Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket.Base-Resolution Analysis of Cisplatin-DNA Adducts at the Genome ScaleNovel strategies for reversing platinum resistance.Increased breast cancer cell toxicity by palladination of the polyamine analogue N (1),N (11)-bis(ethyl)norspermine.Combination of ruthenium(II)-arene complex [Ru(η6-p-cymene)Cl2(pta)] (RAPTA-C) and the epidermal growth factor receptor inhibitor erlotinib results in efficient angiostatic and antitumor activity.Competitive formation of both long-range 5'-5' and short-range antiparallel 3'-3' DNA interstrand cross-links by a trinuclear platinum complex on binding to a 10-mer duplex.Understanding the cross-talk between ovarian tumors and immune cells: mechanisms for effective immunotherapies.Mechanistic studies on the reactions of platinum(II) complexes with nitrogen- and sulfur-donor biomolecules.Amphiphysin 2 (BIN1) in physiology and diseases.Polyamines metabolism and breast cancer: state of the art and perspectives.Enzymatic synthesis of lactosylated and sialylated derivatives of epothilone A.Metal-based drugs that break the rules.Dual-drug delivery of curcumin and platinum drugs in polymeric micelles enhances the synergistic effects: a double act for the treatment of multidrug-resistant cancer.Bag-1 promotes cell survival through c-Myc-mediated ODC upregulation that is not preferred under apoptotic stimuli in MCF-7 cells.Necroptosis-inducing rhenium(V) oxo complexes.The induction of lysis in lysogenic strains of Escherichia coli by a new antitumor transplatin derivative and its DNA interactions.Synergistic antitumor effects of combined deguelin and cisplatin treatment in gastric cancer cellsCisplatin associated with LY294002 increases cytotoxicity and induces changes in transcript profiles of glioblastoma cells.Bidentate ligands on osmium(VI) nitrido complexes control intracellular targeting and cell death pathways.Effect of novel dinuclear platinum(II) complexes on redox status of MOLT-4 leukemic cells.
P2860
Q24613748-0D17C0B9-1DD2-43AD-A2B8-5632CEB201FDQ26745463-181420DF-5B0C-470D-BFE4-078A30C82604Q27684330-D4B84FF6-2280-446D-B7C8-59F655E5AAD0Q28487918-AC631148-4254-498F-9295-CD2E48A8A761Q31143548-D2155A30-9D42-421D-BBC0-922BE46818FAQ33741303-22ADB0BE-337F-4C00-9270-40A111EA3C37Q33847443-880C6016-2A5F-4599-89B5-B8F4B3674A00Q33898518-F68BD7A2-179C-4D65-A98C-0C9BDB775AE2Q34102818-F3D1AEFF-D78C-4811-8638-D79114323E84Q34393918-1D6C5E97-E90A-412A-B050-82E2A8B5CA13Q34396623-785BB056-2738-495F-8DE8-82691C2C8FDBQ34721854-2D69BFE8-B3E1-485A-8BA3-58ED03211463Q34803055-253284E5-6D97-45FB-A718-B65462FBBBF3Q35633069-36239FF3-5611-4A33-97FA-9CC46B52BE4DQ35889822-B45794AC-26CE-4AF9-BBA3-0A06FE63D813Q36287265-C81D1E4D-731D-4B14-895C-FDB473D40DEEQ36302299-CD50FA1E-AA18-4877-A786-D67EC9C849E5Q36465031-039B5591-403D-4DFA-A584-76C7390A7632Q37139330-F8166E42-6740-4C9B-8087-6671248C7AC4Q37229429-E28ABAEC-6D5A-4027-95DF-2AD6DFE008D4Q37320252-F6C0AA65-91F8-4E73-8335-BAA9A82972E9Q37460902-5DAB0857-9EEB-4BA1-A00F-F3A34AAAF7D1Q37461061-4B5DC3D3-BB92-4BC9-A247-6550A9F4D600Q37530925-756A9ACC-8613-411D-A809-B5AB3E91E4A8Q37657640-F1F1DC1A-86BD-4319-A5A0-542E51F69E62Q37732277-DF41E619-C341-45BF-99F0-1F4BBF9A6A30Q37873924-05315DA9-4750-4E7B-A92B-B7A2924761D5Q38034439-20333BBD-88E4-4085-8667-706E035E6E2AQ38192904-2986BA08-0FC4-4189-BA1D-C48AD333AF11Q38257840-B3D9F339-7435-4CA6-A596-BD577ADED1EDQ38417479-5D8B0AF5-8DBC-43B5-A978-472EED06CA99Q38714812-6A057AF4-B56E-4D09-A387-A6B9B3CBE306Q38848963-9FC1235F-3571-4D1D-9493-056B41F9EB44Q38852621-5C224406-FAE9-4E5B-8E48-13232D208946Q38907938-F3E4EC17-C0C2-44EE-BD40-ACBA7C51FE1CQ38939537-CF43D901-98A0-4526-862E-37FF85A43921Q38958264-0E95AE91-58B4-47B3-BFAD-26538A6465D3Q39064313-CF89E35B-8137-45E4-9AF7-12D311F4F753Q39095158-ED85381A-DA1B-4A40-A3C8-BF43375726F2Q39125227-9B089DC1-381A-4CE7-BBC6-B83D23166AB7
P2860
Modifications of DNA by platinum complexes. Relation to resistance of tumors to platinum antitumor drugs.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Modifications of DNA by platin ...... s to platinum antitumor drugs.
@ast
Modifications of DNA by platin ...... s to platinum antitumor drugs.
@en
type
label
Modifications of DNA by platin ...... s to platinum antitumor drugs.
@ast
Modifications of DNA by platin ...... s to platinum antitumor drugs.
@en
prefLabel
Modifications of DNA by platin ...... s to platinum antitumor drugs.
@ast
Modifications of DNA by platin ...... s to platinum antitumor drugs.
@en
P1476
Modifications of DNA by platin ...... rs to platinum antitumor drugs
@en
P2093
Jana Kasparkova
P304
P356
10.1016/J.DRUP.2005.04.006
P577
2005-06-01T00:00:00Z